Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAI Pulse CheckAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Mike Schaefers

Advertisement

Mike Schaefers is chief commercial officer at Simtra BioPharma Solutions.

Articles by Mike Schaefers

研究施設でホログラム画面を見る男性研究者 | Image credit: © metamorworks - © metamorworks - stock.adobe.com

How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs

ByMike Schaefers
February 6th 2026

Integrated CDMO networks streamline complex drug development across advanced modalities like ADCs.

Advertisement

Latest Updated Articles

  • 研究施設でホログラム画面を見る男性研究者 | Image credit: © metamorworks - © metamorworks - stock.adobe.com
    How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs

    February 6th 2026



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Inluriyo-Verzenio Combo Doubles PFS, Adds Oral Complexity

2

Can AI Agents Satisfy CGMP Documentation Requirements?

3

The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push

4

CPHI Milan Brings Back Leadership Summit as Supply Chain and Manufacturing Pressures Ramp Up

5

PharmTech AI Pulse Check: Fixing AI Slop at the Source

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us